The Asian Scientist 100
Yan Ning
Institution
National University of Singapore
Country
Singapore
Field
Environmental Sciences & Geology
For his research on harvesting materials from waste through rational catalytic design, Yan was awarded the 2017 Environment, Sustainability and Energy Division Early Career Award.
(Photo: National University of Singapore)
AWARDS
- 2017 Environment, Sustainability and Energy Division Early Career Award
Related articles
How Gut Cells Chat Like Neurons
Telocytes stretch fine extensions to pass cues to intestinal stem cells.
10 Years Of Celebrating Asia’s Researchers
Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Youth Report Social Media Usage Impacting Their Self Worth And Mental Health
68 percent of the respondents reported difficulties with focusing, and 52 percent admitted they frequently got distracted by social media during their class at school.
Reducing Ozone Pollution Can Prevent Early Deaths In Southeast Asia
Stricter air pollution controls in Southeast Asia could prevent up to 36,000 ozone-related premature deaths annually by 2050.
Ancient Earth Had Green Oceans
Scientists found evidence that cyanobacteria, often called blue-green algae, an important bacteria in the evolutionary process, flourished in green seas.
Superstars Of STEM
This International Women's Day, we are celebrating some powerful women researchers who are empowering others in Asia.
Flag-Bearers Of Innovation
Over the past decade, the National Supercomputing Centre (NSCC) Singapore and collaborators have led the charge in developing supercomputing-powered innovations to support Singapore’s research and development ecosystem.
Amputees Get A Leg Up With New Tech
Researchers and clinicians in Asia continue to advance prosthetic limb technology to make it more effective and accessible for patients in the region.
The Promise Of CAR T-cell Therapy In The Fight Against Cancer
CAR T-cell therapy is becoming an effective alternative for treating diffuse large B-cell lymphoma—offering better outcomes for patients with relapsed or refractory disease.